Mersana Therapeutics Inc’s recent filing unveils that its VP, Chief Accounting Officer Mandelia Ashish unloaded Company’s shares for reported $2061.0 on Jan 16 ’25. In the deal valued at $0.58 per share,3,554 shares were sold. As a result of this transaction, Mandelia Ashish now holds 57,519 shares worth roughly $35086.59.
Then, Protopapas Anna sold 8,637 shares, generating $5,009 in total proceeds. Upon selling the shares at $0.58, the Director now owns 168,041 shares.
Before that, Lowinger Timothy B sold 8,048 shares. Mersana Therapeutics Inc shares valued at $4,668 were divested by the SVP, Chief Sci.&Tech. Officer at a price of $0.58 per share. As a result of the transaction, Lowinger Timothy B now holds 257,673 shares, worth roughly $0.16 million.
A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in mid March from “an Underweight” to “a Neutral”. Wedbush also remained covering MRSN and has increased its forecast on February 29, 2024 with a “an Outperform” recommendation from previously “Neutral” rating. Guggenheim revised its rating on February 29, 2024. It rated MRSN as “a Buy” which previously was an “a Neutral”.
Price Performance Review of MRSN
On Friday, Mersana Therapeutics Inc [NASDAQ:MRSN] saw its stock fall -4.37% to $0.61. Over the last five days, the stock has lost -5.35%. Mersana Therapeutics Inc shares have fallen nearly -57.42% since the year began. Nevertheless, the stocks have fallen -80.36% over the past one year. While a 52-week high of $6.28 was reached on 01/02/25, a 52-week low of $0.49 was recorded on 01/23/25. SMA at 50 days reached $1.5441, while 200 days put it at $1.9931.
Levels Of Support And Resistance For MRSN Stock
The 24-hour chart illustrates a support level at 0.5788, which if violated will result in even more drops to 0.5487. On the upside, there is a resistance level at 0.6412. A further resistance level may holdings at 0.6735. The Relative Strength Index (RSI) on the 14-day chart is 30.18, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0070, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 54.17%. Stochastics %K at 26.46% indicates the stock is a holding.
How much short interest is there in Mersana Therapeutics Inc?
A steep rise in short interest was recorded in Mersana Therapeutics Inc stocks on 2025-01-15, growing by 1.04 million shares to a total of 9.95 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 8.91 million shares. There was a rise of 10.43%, which implies that there is a positive sentiment for the stock.
